These developments represent a sea change for Medicare GLP-1 access and will significantly increase the volume of ePA transactions as millions of previously excluded beneficiaries gain coverage
If you get hot flashes, youre not alone
19 In addition to weight loss, other behavioral strategies such as positional therapy and avoidance of alcohol or sedatives before bedtime may provide modest benefit in selected patients
Whether you are new to mitochondrial peptides or researching SS-31 specifically to add to an existing longevity stack, this is the most complete SS-31 resource available in 2026
An analysis of the market share for various GLP-1 drugs targeting diabetes revealed a significant in sales revenue for Semaglutide (from 2022 to 2023) and Dulaglutide (from 2021 to 2023)
We tested if MOTS-c functions as a mitochondrial-encoded regulator of physical capacity and performance 2,22,23 in young (2 mo.), middle-aged (12 mo.), and old (22 mo.) mice